LNP Delivery System

Cosychem has a proprietary library of over 10,000 ionizable lipids. By tuning lipid structures or formulations, we achieve highly efficient, tissue-specific delivery to the liver, lungs, spleen, muscle, and other tissues. In vivo toxicology data show that our high-performance lipids offer a 50–100 times wider safety window than standard compounds. We provide comprehensive delivery solutions for nucleic acid therapeutics (siRNA, mRNA), gene editing, gene regulation therapies, and multi-organ targeting.

High Encapsulation Efficiency
Minimal Toxicity
Enhanced Stability
Targeted Organ Delivery
Extra-hepatic delivery
Versatile payload compatibility
GMP Scalability
Independent Intellectual property rights

Lipid Nanoparticle (LNP) Services

Target-Specific LNP Structure & Formulation Design

For different nucleic acid modalities (mRNA, siRNA, circRNA, etc.) and therapeutic applications (vaccines, cancer immunotherapy, gene editing), we optimize lipid structures, formulation ratios, particle size, and surface modifications to enhance targeting and stability.

LNP Manufacturing & Process Optimization

Microfluidic synthesis enables scalable production from μg-level lab research to g-level clinical supply with excellent batch consistency.

Stability & Safety Evaluation

LNP in vitro stability studies, safety profiling, and toxicity assessments reduce immunogenicity and off-target risks.

Custom Synthesis of LNP Components

Tailor-made chemistry for the four key LNP components — ionizable lipids, helper lipids, cholesterol, and PEG-lipids — supporting novel molecular library expansion and derivative development.

Intellectual Property Support

Based on a proprietary delivery platform, we provide flexible licensing and customized IP transformation services for ionizable lipids and LNP formulations.

For more organ-targeting options,
please contact us.

Value of the Cosynbio LNP Delivery Platform

Breaking Delivery Barriers ----- Enhancing stability, specificity, and reducing immunogenicity for nucleic acid drugs

Fast-Track Translation ----- Industrialized workflows and integrated services shorten development timelines.

Risk-Free IP Collaboration ----- Evaluation → Verification → Licensing model enabling secure commercialization for partners.